Impact of risk factors for 5-year EFS and incidence of molecular relapse.<sup>a)</sup>

Table 4Impact of risk factors for 5-year EFS and incidence of molecular relapse.<sup>a)</sup>

^a)Data for a subset of all risk factors analyzed. ^b)Additional cytogenetic abnormalities besides Ph. ^c)Based on RQ-PCR of the fusion transcript. ^d)RQ-PCR value of ‘0.’

Abbreviations: Consol., Consolidation; Dexa, dexamethasone; HCT, hematopoietic cell transplantation; HLA, human leukocyte antigen; Pred, prednisolone.

Blood Res 2019;54:45~51 https://doi.org/10.5045/br.2019.54.1.45